Cargando…

Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol

Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Komorowska, Dominika, Radzik, Tomasz, Kalenik, Sebastian, Rodacka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501384/
https://www.ncbi.nlm.nih.gov/pubmed/36142554
http://dx.doi.org/10.3390/ijms231810627
_version_ 1784795461347966976
author Komorowska, Dominika
Radzik, Tomasz
Kalenik, Sebastian
Rodacka, Aleksandra
author_facet Komorowska, Dominika
Radzik, Tomasz
Kalenik, Sebastian
Rodacka, Aleksandra
author_sort Komorowska, Dominika
collection PubMed
description Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding the molecular mechanisms of carcinogenesis and developments in modern radiotherapy techniques, radiotherapy (alone or in combination) does not always guarantee treatment success. One of the main causes is the radioresistance of cancer cells. Increasing the radiosensitivity of cancer cells improves the processes leading to their elimination during radiotherapy and prolonging the survival of cancer patients. In order to enhance the effect of radiotherapy in the treatment of radioresistant neoplasms, radiosensitizers are used. In clinical practice, synthetic radiosensitizers are commonly applied, but scientists have recently focused on using natural products (phytocompounds) as adjuvants in radiotherapy. In this review article, we only discuss naturally occurring radiosensitizers currently in clinical trials (paclitaxel, curcumin, genistein, and papaverine) and those whose radiation sensitizing effects, such as resveratrol, have been repeatedly confirmed by many independent studies.
format Online
Article
Text
id pubmed-9501384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95013842022-09-24 Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol Komorowska, Dominika Radzik, Tomasz Kalenik, Sebastian Rodacka, Aleksandra Int J Mol Sci Review Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding the molecular mechanisms of carcinogenesis and developments in modern radiotherapy techniques, radiotherapy (alone or in combination) does not always guarantee treatment success. One of the main causes is the radioresistance of cancer cells. Increasing the radiosensitivity of cancer cells improves the processes leading to their elimination during radiotherapy and prolonging the survival of cancer patients. In order to enhance the effect of radiotherapy in the treatment of radioresistant neoplasms, radiosensitizers are used. In clinical practice, synthetic radiosensitizers are commonly applied, but scientists have recently focused on using natural products (phytocompounds) as adjuvants in radiotherapy. In this review article, we only discuss naturally occurring radiosensitizers currently in clinical trials (paclitaxel, curcumin, genistein, and papaverine) and those whose radiation sensitizing effects, such as resveratrol, have been repeatedly confirmed by many independent studies. MDPI 2022-09-13 /pmc/articles/PMC9501384/ /pubmed/36142554 http://dx.doi.org/10.3390/ijms231810627 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Komorowska, Dominika
Radzik, Tomasz
Kalenik, Sebastian
Rodacka, Aleksandra
Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title_full Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title_fullStr Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title_full_unstemmed Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title_short Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
title_sort natural radiosensitizers in radiotherapy: cancer treatment by combining ionizing radiation with resveratrol
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501384/
https://www.ncbi.nlm.nih.gov/pubmed/36142554
http://dx.doi.org/10.3390/ijms231810627
work_keys_str_mv AT komorowskadominika naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol
AT radziktomasz naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol
AT kaleniksebastian naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol
AT rodackaaleksandra naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol